查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球小鼠模型市场：模型类型、服务、技术、应用和最终用户的未来预测（至 2028 年）
市场调查报告书
商品编码
1263191

全球小鼠模型市场：模型类型、服务、技术、应用和最终用户的未来预测（至 2028 年）

Mice Model Market by Model Types & Services, Technology, Application, End User - Global Forecast to 2028
出版日期: | 出版商: MarketsandMarkets | 英文 227 Pages | 订单完成后即时交付

价格
简介目录

到 2028 年，全球鼠标模型市场规模预计将从 2023 年的 14 亿美元达到 27 亿美元，预测期内復合年增长率为 13.9%。

推动小鼠模型市场增长的主要因素是药物发现领域的各种优势和技术的高效性。 然而，替代动物研究模型的存在预计会在一定程度上抑制市场增长。

“按应用来看，PDx模型/异种移植部分在小鼠模型市场占有最大份额”

2022 年，PDx 模型/异种移植部分主导了市场，因为免疫功能低下的小鼠模型越来越倾向于个性化医疗。 个性化医疗是通过使用小鼠模型设计的。

“按最终用户划分，製药和生物技术公司在小鼠模型市场中所占份额最大”

到 2022 年，製药和生物技术公司将占据小鼠模型市场的更大份额。 该细分市场的驱动因素包括公司增加用于药物开发的研发 (R&D) 支出。

“北美：鼠标模型市场份额最大”

北美占据鼠标模型市场的最大份额。 北美的巨大份额可归因于合同研究组织 (CRO) 和生物製药公司的临床前活动增加，以及生物医学研究的显着增加。 此外，美国鼠标模型市场的主要参与者的存在正在推动市场的增长。

“亚太地区：小鼠模型市场增长最快的地区”

在预测期内，亚太地区鼠标模型市场预计将以最高复合年增长率增长。 这是由于许多国内外公司正在进入该地区并增加其影响力。 另一方面，国内公司正在通过商业联盟、合作、合同和扩张扩大其国际影响力。 其他包括对个性化和再生医学不断增长的需求，在中国开展研发活动的国际合作，以及对药品和化妆品的强制性动物试验。

内容

第一章介绍

第二章研究方法论

第 3 章执行摘要

第 4 章重要注意事项

第 5 章市场概述

  • 介绍
  • 市场动态
    • 司机
    • 约束因素
    • 机会
    • 任务
  • 技术分析
  • 影响客户业务的趋势/颠覆
  • 供应炼和价值链分析
  • 生态系统分析
  • 波特的五力分析
  • 监管分析
  • 专利分析
  • 价格分析
  • 主要会议
  • 主要利益相关者和采购标准

第 6 章鼠标模型市场：按模型类型和服务

  • 介绍
  • 模型类型
    • 介绍
    • 近交系小鼠
    • 远交小鼠
    • 基因工程小鼠
    • 杂交/同类小鼠
  • 服务
    • 介绍
    • 育种服务
    • 冷冻保存服务
    • 重新派生服务
    • 检疫服务
    • 其他服务

第 7 章小鼠模型市场：按应用

  • 介绍
  • 药物发现和开发
  • 基础研究
  • PDx 模型/异种移植

第 8 章小鼠模型市场：按技术分类

  • 介绍
  • CRISPR/CAS9
  • 显微注射
  • 胚胎干细胞注射
  • 核转移
  • 其他技术

第 9 章鼠标模型市场：按最终用户分类

  • 介绍
  • 製药和生物技术公司
  • CRO□CDMO
  • 学术和研究机构

第 10 章鼠标模型市场：按地区

  • 介绍
  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 意大利
    • 西班牙
    • 其他欧洲
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳大利亚
    • 其他亚太地区
  • 拉丁美洲
  • 中东和非洲

第11章竞争格局

  • 介绍
  • 主要公司采用的策略
  • 收入份额分析（前 4 家公司）
  • 企业评估象限：国际公司
  • 商业评估象限：初创公司/中小企业
  • 竞争情景和趋势

第12章公司简介

  • 主要公司
    • CHARLES RIVER LABORATORIES
    • THE JACKSON LABORATORY
    • INOTIV
    • GENOWAY
    • TACONIC BIOSCIENCES, INC.
    • JANVIER LABS
    • HARBOUR BIOMED
    • TRANS GENIC INC.
    • INGENIOUS TARGETING LABORATORY
    • POLYGENE
    • ARAGEN LIFE SCIENCES LTD.
    • CYAGEN BIOSCIENCES
    • CROWN BIOSCIENCE
    • TRANSCURE BIOSERVICES
    • OZGENE PTY LTD.
  • 其他企业
    • THE ANDERSONS, INC.
    • ALLENTOWN, LLC
    • INNOVIVE
    • LAB PRODUCTS, LLC.
    • CRESCENDO BIOLOGICS
    • IMMUNOGENES
    • LEXICON PHARMACEUTICALS, INC.
    • HORIZON DISCOVERY LTD.
    • MARSHALL BIORESOURCES
    • APPLIED STEMCELL

第13章 附录

简介目录
Product Code: BT 2192

The mice model market is projected to reach USD 2.7 billion by 2028 from USD 1.4 billion in 2023, at a CAGR of 13.9% during the forecast period. The key factors driving the growth of the mice model market are its various advantages in the drug discovery sector, and the high efficiency of the technologies. However, the presence of alternative animal research models is expected to restrain market growth to a certain extent.

The mice model market has been segmented based on model types & services, technology, application, end user, and region.

"By application, the PDx models/ xenografts segment accounted for the largest share of the mice model market"

Based on application, the mice model market is categorized into drug discovery and development, basic research, and PDX models/ xenografts. The PDx models/ xenografts segment dominated the market in 2022, owing to the growing preference for personalized medicine in immunodeficient mice models. Personalized medicines are designed through the use of mice models.

"By end user, the pharmaceutical & biotechnology companies segment accounted for the largest share in the mice model market"

Based on end user, the Mice model market is segmented into academic & research institutions, pharmaceutical & biotechnology companies, contract research organizations (CROs) and contract development & manufacturing organizations. In 2022, the pharmaceutical and biotechnology companies' segment accounted for a larger share of the mice model market. Growth in this market segment can be attributed to the increasing expenditure on R&D by companies for drug development.

"North America: the largest share of the mice model market"

North America accounted for the largest share of the mice model market. The large share of the North America region can be attributed to a rise in the preclinical activities by contract research organizations and the biopharmaceutical companies, and a significant increase in the biomedical research. Moreover, presence of key players in the mice model market in the U.S. are propelling the growth of the market.

"Asia Pacific: The fastest-growing region in the mice model market."

The Asia Pacific mice model market is projected to grow at the highest CAGR during the forecast period. This is attributed to increasing numbers of both domestic and international market players which are focusing on increasing their prescence in the region. Meanwhile, domestic players are expanding their international reach through partnerships, collaborations, agreements, and expansions. Moreover, increasing demand for personalized medicine and regenerative medicine, international alliances for R&D activities in China, and mandatory animal testing for pharmaceutical drugs & cosmetics.

The primary interviews conducted for this report can be categorized as follows:

  • By Respondent: Supply Side- 60% and Demand Side 40%
  • By Designation: Executives - 40%, Research Scientists- 30%, and Managers - 30%
  • By Country: North America- 22%, Europe- 42%, Asia Pacific- 11%, Latin America- 20%, and MEA- 5%

Prominent Players

  • Charles River Laboratories (US)
  • The Jackson Laboratory (US)
  • Inotiv (US)
  • genOway (France)
  • Taconic Biosciences, Inc. (US)
  • Janvier Labs (France)
  • Harbour BioMed (China)
  • Trans Genic Inc. (Japan)
  • Ingenious Targeting Laboratory (US)
  • PolyGene AG (Switzerland)
  • Aragen Life Sciences Ltd. (India)
  • Cyagen Biosciences (US)
  • Crown Biosciences (US)
  • TransCure bioServices (France)
  • Ozgene Pty. Ltd. (Australia)
  • The Andersons, Inc. (US)
  • Allentown, LLC (US)
  • Innovive (US)
  • Lab Products, LLC. (US)
  • Crescendo Biologics Limited (UK)
  • ImmunoGenes (Hungary)
  • Lexicon Pharmaceuticals, Inc. (US)
  • Horizon Discovery Ltd (UK)
  • Marshall BioResources (US)
  • Applied StemCell Inc. (US)

Research Coverage:

This report provides a detailed picture of the mice model market. It aims at estimating the size and future growth potential of the market across different segments, such as the model types and services (model types, services), technology (CRISPR/CAS9, microinjection, embryonic stem cell injection, nuclear transfer, and other technologies), application (drug discovery & development, basic research, and PDx models/xenografts), end user (academic & research institutes, pharma & biotech companies, and CROs & CDMOs), and region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa). The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall mice model market and its segments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, trends, opportunities, and challenges.

The report provide insights on the following pointers"

  • Analysis of key drivers (rising investments in mouse-model based research, increasing demand of mouse-based clinical trials (MCTs) for more productive outcomes, and the growing preference for personalized medicine), restraints (introduction of 3D-printed mouse models), opportunities (utilization of CRISPR in biomedical research), and challenges (development of alternative animal testing methods) . influencing the growth of the mice model market.
  • Product Development/ Innovation: Detailed insights on upcoming technologies, research and development activities, and new models & services launches in the mice model market.
  • Market Development: Comprehensive information about lucrative markets- the report analyses the mice model market across varied regions.
  • Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the mice model market.
  • Competitive Assessment: In-depth assessment of market shares, growth strategies and service offerings of leading players like Charles River Laboratories (US) (US), The Jackson Laboratory (US), Inotiv (US), genOway (France), and Taconic Biosciences, Inc. (US) among others in the mice model market strategies. The report also helps stakeholders understand the pulse of the animal research model market and provides them information on key market drivers, restraints, challenges and opportunities.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS AND EXCLUSIONS
  • 1.3 STUDY SCOPE
  • 1.4 YEARS CONSIDERED
  • 1.5 CURRENCY CONSIDERED
  • 1.6 RESEARCH LIMITATIONS
  • 1.7 STAKEHOLDERS
    • 1.7.1 RECESSION IMPACT

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 1 RESEARCH DESIGN
    • 2.1.1 SECONDARY DATA
    • 2.1.2 PRIMARY DATA
    • FIGURE 2 MICE MODEL MARKET: BREAKDOWN OF PRIMARIES
  • 2.2 MARKET ESTIMATION METHODOLOGY
    • FIGURE 3 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION)
    • FIGURE 4 MICE MODEL MARKET SIZE (USD MILLION)
    • FIGURE 5 MICE MODEL MARKET: FINAL CAGR PROJECTION (2023-2028)
    • FIGURE 6 MICE MODEL MARKET: CAGR PROJECTION FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • 2.3 MARKET DATA ESTIMATION AND TRIANGULATION
    • 2.3.1 DATA TRIANGULATION
    • FIGURE 7 DATA TRIANGULATION METHODOLOGY
  • 2.4 INDUSTRY INSIGHTS
  • 2.5 STUDY ASSUMPTIONS
  • 2.6 RECESSION IMPACT: MICE MODEL MARKET
    • TABLE 1 GLOBAL INFLATION RATE PROJECTION, 2023-2028 (% GROWTH)
    • TABLE 2 US HEALTH EXPENDITURE, 2019-2022 (USD MILLION)
    • TABLE 3 US HEALTH EXPENDITURE, 2023-2027 (USD MILLION)

3 EXECUTIVE SUMMARY

    • FIGURE 8 MICE MODEL MARKET, BY MODEL TYPE AND SERVICE, 2023 VS. 2028 (USD MILLION)
    • FIGURE 9 MICE MODEL MARKET, BY TECHNOLOGY, 2023 VS. 2028 (USD MILLION)
    • FIGURE 10 MICE MODEL MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
    • FIGURE 11 MICE MODEL MARKET: GEOGRAPHICAL SNAPSHOT

4 PREMIUM INSIGHTS

  • 4.1 MICE MODEL MARKET OVERVIEW
    • FIGURE 12 INCREASING DEMAND FOR MOUSE-BASED CLINICAL TRIALS TO DRIVE MARKET
  • 4.2 NORTH AMERICA: MICE MODEL MARKET, BY MODEL TYPE AND SERVICE (2022)
    • FIGURE 13 MICE MODELS SEGMENT IN THE US ACCOUNTED FOR LARGEST MARKET SHARE
  • 4.3 MICE MODEL MARKET SHARE, BY END USER, 2023 VS. 2028
    • FIGURE 14 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
  • 4.4 MICE MODEL MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    • FIGURE 15 CHINA TO REGISTER HIGHEST GROWTH RATE IN ASIA PACIFIC MARKET DURING FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 16 MICE MODEL MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • TABLE 4 MICE MODEL MARKET: IMPACT ANALYSIS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Rising investments in mouse model-based research
      • 5.2.1.2 Increasing demand for mouse-based clinical trials (MCTs)
      • 5.2.1.3 Growing preference for personalized medicine
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Introduction of 3D-printed mouse models
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Utilization of CRISPR in biomedical research
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Development of alternative animal testing methods
  • 5.3 TECHNOLOGY ANALYSIS
  • 5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
    • FIGURE 17 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • 5.5 SUPPLY AND VALUE CHAIN ANALYSIS
    • 5.5.1 MICE MODEL MARKET: SUPPLY CHAIN ANALYSIS
    • FIGURE 18 MICE MODEL MARKET: SUPPLY CHAIN MAP
    • 5.5.2 MICE MODEL MARKET: VALUE CHAIN MAP
    • FIGURE 19 MICE MODEL MARKET: VALUE CHAIN MODEL
  • 5.6 ECOSYSTEM ANALYSIS
    • FIGURE 20 MICE MODEL MARKET: ECOSYSTEM MAP
  • 5.7 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 5 MICE MODEL MARKET: PORTER'S FIVE FORCES ANALYSIS
    • 5.7.1 THREAT OF NEW ENTRANTS
    • 5.7.2 THREAT OF SUBSTITUTES
    • 5.7.3 BARGAINING POWER OF BUYERS
    • 5.7.4 BARGAINING POWER OF SUPPLIERS
    • 5.7.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.8 REGULATORY ANALYSIS
    • 5.8.1 INTRODUCTION
    • 5.8.2 NORTH AMERICA
    • 5.8.3 EUROPE
    • 5.8.4 CHINA
    • 5.8.5 JAPAN
    • 5.8.6 INDIA
    • 5.8.7 AUSTRALIA
    • 5.8.8 BRAZIL
  • 5.9 PATENT ANALYSIS
    • FIGURE 21 MICE MODEL MARKET: PATENT FILING TRENDS (2010-2022)
  • 5.10 PRICING ANALYSIS
    • TABLE 6 AVERAGE SELLING PRICE OF PRODUCTS BY MANUFACTURERS
    • 5.10.1 MICE MODEL MARKET: AVERAGE SELLING PRICE TREND ANALYSIS
  • 5.11 KEY CONFERENCES
    • 5.11.1 MICE MODEL MARKET: KEY CONFERENCES (2023)
    • TABLE 7 MICE MODEL MARKET: KEY CONFERENCES (2023)
  • 5.12 KEY STAKEHOLDERS AND BUYING CRITERIA
    • 5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • FIGURE 22 MICE MODEL MARKET: INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS
    • 5.12.2 MICE MODEL MARKET: KEY BUYING CRITERIA
    • FIGURE 23 KEY BUYING CRITERIA FOR END USERS

6 MICE MODEL MARKET, BY MODEL TYPE AND SERVICE

  • 6.1 INTRODUCTION
    • TABLE 8 MICE MODEL MARKET, BY MODEL TYPE AND SERVICE, 2021-2028 (USD MILLION)
  • 6.2 MODEL TYPE
    • 6.2.1 INTRODUCTION
    • TABLE 9 MICE MODEL MARKET, BY MODEL TYPE, 2021-2028 (USD MILLION)
    • 6.2.2 INBRED MICE
      • 6.2.2.1 Growing applications of inbred mice in mAb production and pharmacology to drive market
    • TABLE 10 INBRED MICE MODEL MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 11 NORTH AMERICA: INBRED MICE MODEL MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 12 EUROPE: INBRED MICE MODEL MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 13 ASIA PACIFIC: INBRED MICE MODEL MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • 6.2.3 OUTBRED MICE
      • 6.2.3.1 Genetic diversity offered by outbred mice to drive market
    • TABLE 14 OUTBRED MICE MODEL MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 15 NORTH AMERICA: OUTBRED MICE MODEL MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 16 EUROPE: OUTBRED MICE MODEL MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 17 ASIA PACIFIC: OUTBRED MICE MODEL MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • 6.2.4 GENETICALLY ENGINEERED MICE
      • 6.2.4.1 Increasing focus on personalized medicine for cancer and CVD to drive segment growth
    • TABLE 18 GENETICALLY ENGINEERED MICE MODEL MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 19 NORTH AMERICA: GENETICALLY ENGINEERED MICE MODEL MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 20 EUROPE: GENETICALLY ENGINEERED MICE MODEL MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 21 ASIA PACIFIC: GENETICALLY ENGINEERED MICE MODEL MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • 6.2.5 HYBRID/CONGENIC MICE
      • 6.2.5.1 Increasing demand for congenic mice in biomedical research to drive market
    • TABLE 22 HYBRID/CONGENIC MICE MODEL MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 23 NORTH AMERICA: HYBRID/CONGENIC MICE MODEL MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 24 EUROPE: HYBRID/CONGENIC MICE MODEL MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 25 ASIA PACIFIC: HYBRID/CONGENIC MICE MODEL MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • 6.3 SERVICES
    • 6.3.1 INTRODUCTION
    • TABLE 26 MICE MODEL MARKET, BY SERVICES, 2021-2028 (USD MILLION)
    • 6.3.2 BREEDING SERVICES
      • 6.3.2.1 Growing number of mice model studies to fuel market
    • TABLE 27 MICE MODEL MARKET FOR BREEDING SERVICES, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 28 NORTH AMERICA: MICE MODEL MARKET FOR BREEDING SERVICES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 29 EUROPE: MICE MODEL MARKET FOR BREEDING SERVICES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 30 ASIA PACIFIC: MICE MODEL MARKET FOR BREEDING SERVICES, BY COUNTRY, 2021-2028 (USD MILLION)
    • 6.3.3 CRYOPRESERVATION SERVICES
      • 6.3.3.1 Rising need for preservation of novel mice models to drive market
    • TABLE 31 MICE MODEL MARKET FOR CRYOPRESERVATION SERVICES, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 32 NORTH AMERICA: MICE MODEL MARKET FOR CRYOPRESERVATION SERVICES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 33 EUROPE: MICE MODEL MARKET FOR CRYOPRESERVATION SERVICES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 34 ASIA PACIFIC: MICE MODEL MARKET FOR CRYOPRESERVATION SERVICES, BY COUNTRY, 2021-2028 (USD MILLION)
    • 6.3.4 REDERIVATION SERVICES
      • 6.3.4.1 Stringent quality assurance standards to drive market
    • TABLE 35 MICE MODEL MARKET FOR REDERIVATION SERVICES, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 36 NORTH AMERICA: MICE MODEL MARKET FOR REDERIVATION SERVICES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 37 EUROPE: MICE MODEL MARKET FOR REDERIVATION SERVICES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 38 ASIA PACIFIC: MICE MODEL MARKET FOR REDERIVATION SERVICES, BY COUNTRY, 2021-2028 (USD MILLION)
    • 6.3.5 QUARANTINE SERVICES
      • 6.3.5.1 Rising demand for germ-free mice in histopathology and serology applications to drive market
    • TABLE 39 MICE MODEL MARKET FOR QUARANTINE SERVICES, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 40 NORTH AMERICA: MICE MODEL MARKET FOR QUARANTINE SERVICES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 41 EUROPE: MICE MODEL MARKET FOR QUARANTINE SERVICE, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 42 ASIA PACIFIC: MICE MODEL MARKET FOR QUARANTINE SERVICES, BY COUNTRY, 2021-2028 (USD MILLION)
    • 6.3.6 OTHER SERVICES
    • TABLE 43 MICE MODEL MARKET FOR OTHER SERVICES, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 44 NORTH AMERICA: MICE MODEL MARKET FOR OTHER SERVICES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 45 EUROPE: MICE MODEL MARKET FOR OTHER SERVICES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 46 ASIA PACIFIC: MICE MODEL MARKET FOR OTHER SERVICES, BY COUNTRY, 2021-2028 (USD MILLION)

7 MICE MODEL MARKET, BY APPLICATION

  • 7.1 INTRODUCTION
    • TABLE 47 MICE MODEL MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • 7.2 DRUG DISCOVERY & DEVELOPMENT
    • 7.2.1 RISING NUMBER OF CLINICAL TRIALS TO DRIVE DEMAND FOR MICE MODELS
    • TABLE 48 MICE MODEL MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 49 NORTH AMERICA: MICE MODEL MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 50 EUROPE: MICE MODEL MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 51 ASIA PACIFIC: MICE MODEL MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2021-2028 (USD MILLION)
  • 7.3 BASIC RESEARCH
    • 7.3.1 INCREASING FUNDS FOR CANCER RESEARCH ON MICE MODELS TO SUPPORT MARKET GROWTH
    • TABLE 52 MICE MODEL MARKET FOR BASIC RESEARCH, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 53 NORTH AMERICA: MICE MODEL MARKET MODEL MARKET FOR BASIC RESEARCH, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 54 EUROPE: MICE MODEL MARKET FOR BASIC RESEARCH, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 55 ASIA PACIFIC: MICE MODEL MARKET FOR BASIC RESEARCH, BY COUNTRY, 2021-2028 (USD MILLION)
  • 7.4 PDX MODELS/ XENOGRAFTS
    • 7.4.1 GROWING PREFERENCE FOR PERSONALIZED MEDICINE IN IMMUNODEFICIENT MICE MODELS TO DRIVE MARKET
    • TABLE 56 MICE MODEL MARKET FOR PDX MODELS/XENOGRAFTS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 57 NORTH AMERICA: MICE MODEL MARKET FOR PDX MODELS/XENOGRAFTS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 58 EUROPE: MICE MODEL MARKET FOR PDX MODELS/XENOGRAFTS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 59 ASIA PACIFIC: MICE MODEL MARKET FOR PDX MODELS/XENOGRAFTS, BY COUNTRY, 2021-2028 (USD MILLION)

8 MICE MODEL MARKET, BY TECHNOLOGY

  • 8.1 INTRODUCTION
    • TABLE 60 MICE MODEL MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
  • 8.2 CRISPR/CAS9
    • 8.2.1 HIGH EFFICIENCY AND COST-EFFECTIVE BENEFITS TO DRIVE DEMAND FOR CRISPR-CUSTOMIZED MODELS
    • TABLE 61 MICE MODEL MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 62 NORTH AMERICA: MICE MODEL MARKET FOR CRISPR/CAS9, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 63 EUROPE: MICE MODEL MARKET FOR CRISPR/CAS9 TECHNOLOGY, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 64 ASIA PACIFIC: MICE MODEL MARKET FOR CRISPR/CAS9, BY COUNTRY, 2021-2028 (USD MILLION)
  • 8.3 MICROINJECTION
    • 8.3.1 WIDELY UTILIZED TECHNIQUE FOR DEVELOPMENT OF TRANSGENIC MICE MODELS TO DRIVE MARKET
    • TABLE 65 NORTH AMERICA: MICE MODEL MARKET FOR MICROINJECTION, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 66 EUROPE: MICE MODEL MARKET FOR MICROINJECTION, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 67 ASIA PACIFIC: MICE MODEL MARKET FOR MICROINJECTION, BY COUNTRY, 2021-2028 (USD MILLION)
  • 8.4 EMBRYONIC STEM CELL INJECTION
    • 8.4.1 GROWING DEMAND FOR TARGETED MICE MODELS TO DRIVE MARKET
    • TABLE 68 NORTH AMERICA: MICE MODEL MARKET FOR EMBRYONIC STEM CELL INJECTION, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 69 EUROPE: MICE MODEL MARKET FOR EMBRYONIC STEM CELL INJECTION, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 70 ASIA PACIFIC: MICE MODEL MARKET FOR EMBRYONIC STEM CELL INJECTION, BY COUNTRY, 2021-2028 (USD MILLION)
  • 8.5 NUCLEAR TRANSFER
    • 8.5.1 POTENTIAL TO PRODUCE IDENTICAL MICE TO DRIVE MARKET
    • TABLE 71 NORTH AMERICA: MICE MODEL MARKET FOR NUCLEAR TRANSFER, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 72 EUROPE: MICE MODEL MARKET FOR NUCLEAR TRANSFER, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 73 ASIA PACIFIC: MICE MODEL MARKET FOR NUCLEAR TRANSFER, BY COUNTRY, 2021-2028 (USD MILLION)
  • 8.6 OTHER TECHNOLOGIES
    • TABLE 74 NORTH AMERICA: MICE MODEL MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 75 EUROPE: MICE MODEL MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 76 ASIA PACIFIC: MICE MODEL MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021-2028 (USD MILLION)

9 MICE MODEL MARKET, BY END USER

  • 9.1 INTRODUCTION
    • TABLE 77 MICE MODEL MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 9.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
    • 9.2.1 EXTENSIVE USE OF MICE MODELS IN CANCER THERAPEUTICS TO DRIVE MARKET
    • TABLE 78 MICE MODEL MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 79 NORTH AMERICA: MICE MODEL MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 80 EUROPE: MICE MODEL MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 81 ASIA PACIFIC: MICE MODEL MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
  • 9.3 CONTRACT RESEARCH ORGANIZATIONS AND CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATIONS
    • 9.3.1 RISING OUTSOURCING OF DRUG DISCOVERY SERVICES TO DRIVE MARKET
    • TABLE 82 MICE MODEL MARKET FOR CROS AND CDMOS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 83 NORTH AMERICA: MICE MODEL MARKET FOR CROS AND CDMOS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 84 EUROPE: MICE MODEL MARKET FOR CROS AND CDMOS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 85 ASIA PACIFIC: MICE MODEL MARKET FOR CROS AND CDMOS, BY COUNTRY, 2021-2028 (USD MILLION)
  • 9.4 ACADEMIC & RESEARCH INSTITUTES
    • 9.4.1 INCREASE IN GOVERNMENT LIFE SCIENCES R&D EXPENDITURE TO DRIVE MARKET
    • TABLE 86 MICE MODEL MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 87 NORTH AMERICA: MICE MODEL MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 88 EUROPE: MICE MODEL MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 89 ASIA PACIFIC: MICE MODEL MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021-2028 (USD MILLION)

10 MICE MODEL MARKET, BY REGION

  • 10.1 INTRODUCTION
    • FIGURE 24 MICE MODEL MARKET, BY REGION, 2023 VS. 2028 (USD MILLION)
    • TABLE 90 MICE MODEL MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 10.2 NORTH AMERICA
    • FIGURE 25 NORTH AMERICA: MICE MODEL MARKET SNAPSHOT
    • TABLE 91 NORTH AMERICA: MICE MODEL MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 92 NORTH AMERICA: MICE MODEL MARKET, BY MODEL TYPE AND SERVICE, 2021-2028 (USD MILLION)
    • TABLE 93 NORTH AMERICA: MICE MODEL MARKET, BY MODEL TYPE, 2021-2028 (USD MILLION)
    • TABLE 94 NORTH AMERICA: MICE MODEL MARKET, BY SERVICE, 2021-2028 (USD MILLION)
    • TABLE 95 NORTH AMERICA: MICE MODEL MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 96 NORTH AMERICA: MICE MODEL MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 97 NORTH AMERICA: MICE MODEL MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.2.1 US
      • 10.2.1.1 Rising production of monoclonal antibodies to fuel market for mice models
    • TABLE 98 US: MICE MODEL MARKET, BY MODEL TYPE AND SERVICE, 2021-2028 (USD MILLION)
    • TABLE 99 US: MICE MODEL MARKET, BY MODEL TYPE, 2021-2028 (USD MILLION)
    • TABLE 100 US: MICE MODEL MARKET, BY SERVICE, 2021-2028 (USD MILLION)
    • TABLE 101 US: MICE MODEL MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 102 US: MICE MODEL MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 103 US: MICE MODEL MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.2.2 CANADA
      • 10.2.2.1 Rising activities in stem cell research to drive adoption of mice models
    • TABLE 104 CANADA: MICE MODEL MARKET, BY MODEL TYPE AND SERVICE, 2021-2028 (USD MILLION)
    • TABLE 105 CANADA: MICE MODEL MARKET, BY MODEL TYPE, 2021-2028 (USD MILLION)
    • TABLE 106 CANADA: MICE MODEL MARKET, BY SERVICE, 2021-2028 (USD MILLION)
    • TABLE 107 CANADA: MICE MODEL MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 108 CANADA: MICE MODEL MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 109 CANADA: MICE MODEL MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.2.3 NORTH AMERICA: RECESSION IMPACT
  • 10.3 EUROPE
    • TABLE 110 EUROPE: MICE MODEL MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 111 EUROPE: MICE MODEL MARKET, BY MODEL TYPE AND SERVICE, 2021-2028 (USD MILLION)
    • TABLE 112 EUROPE: MICE MODEL MARKET, BY MODEL TYPE, 2021-2028 (USD MILLION)
    • TABLE 113 EUROPE: MICE MODEL MARKET, BY SERVICE, 2021-2028 (USD MILLION)
    • TABLE 114 EUROPE: MICE MODEL MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 115 EUROPE: MICE MODEL MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 116 EUROPE: MICE MODEL MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.3.1 GERMANY
      • 10.3.1.1 Rising research activities in biotechnology industry to drive market
    • TABLE 117 GERMANY: MICE MODEL MARKET, BY MODEL TYPE AND SERVICE, 2021-2028 (USD MILLION)
    • TABLE 118 GERMANY: MICE MODEL MARKET, BY MODEL TYPE, 2021-2028 (USD MILLION)
    • TABLE 119 GERMANY: MICE MODEL MARKET, BY SERVICE, 2021-2028 (USD MILLION)
    • TABLE 120 GERMANY: MICE MODEL MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 121 GERMANY: MICE MODEL MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 122 GERMANY: MICE MODEL MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.3.2 FRANCE
      • 10.3.2.1 Rising research in proteomics & genomics to drive adoption of genetically engineered mice models
    • TABLE 123 FRANCE: MICE MODEL MARKET, BY MODEL TYPE AND SERVICE, 2021-2028 (USD MILLION)
    • TABLE 124 FRANCE: MICE MODEL MARKET, BY MODEL TYPE, 2021-2028 (USD MILLION)
    • TABLE 125 FRANCE: MICE MODEL MARKET, BY SERVICE, 2021-2028 (USD MILLION)
    • TABLE 126 FRANCE: MICE MODEL MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 127 FRANCE: MICE MODEL MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 128 FRANCE: MICE MODEL MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.3.3 UK
      • 10.3.3.1 Increasing focus on cancer research to drive market
    • TABLE 129 UK: MICE MODEL MARKET, BY MODEL TYPE AND SERVICE, 2021-2028 (USD MILLION)
    • TABLE 130 UK: MICE MODEL MARKET, BY MODEL TYPE, 2021-2028 (USD MILLION)
    • TABLE 131 UK: MICE MODEL MARKET, BY SERVICE, 2021-2028 (USD MILLION)
    • TABLE 132 UK: MICE MODEL MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 133 UK: MICE MODEL MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 134 UK: MICE MODEL MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.3.4 ITALY
      • 10.3.4.1 Rising demand for preclinical research in pharmaceutical & biotechnology industry to support market growth
    • TABLE 135 ITALY: MICE MODEL MARKET, BY MODEL TYPE AND SERVICE, 2021-2028 (USD MILLION)
    • TABLE 136 ITALY: MICE MODEL MARKET, BY MODEL TYPE, 2021-2028 (USD MILLION)
    • TABLE 137 ITALY: MICE MODEL MARKET, BY SERVICE, 2021-2028 (USD MILLION)
    • TABLE 138 ITALY: MICE MODEL MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 139 ITALY: MICE MODEL MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 140 ITALY: MICE MODEL MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.3.5 SPAIN
      • 10.3.5.1 High number of pharmaceutical laboratories to fuel market for mice models
    • TABLE 141 SPAIN: MICE MODEL MARKET, BY MODEL TYPE AND SERVICE, 2021-2028 (USD MILLION)
    • TABLE 142 SPAIN: MICE MODEL MARKET, BY MODEL TYPE, 2021-2028 (USD MILLION)
    • TABLE 143 SPAIN: MICE MODEL MARKET, BY SERVICE, 2021-2028 (USD MILLION)
    • TABLE 144 SPAIN: MICE MODEL MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 145 SPAIN: MICE MODEL MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 146 SPAIN: MICE MODEL MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.3.6 REST OF EUROPE
    • TABLE 147 REST OF EUROPE: MICE MODEL MARKET, BY MODEL TYPE AND SERVICE, 2021-2028 (USD MILLION)
    • TABLE 148 REST OF EUROPE: MICE MODEL MARKET, BY MODEL TYPE, 2021-2028 (USD MILLION)
    • TABLE 149 REST OF EUROPE: MICE MODEL MARKET, BY SERVICE, 2021-2028 (USD MILLION)
    • TABLE 150 REST OF EUROPE: MICE MODEL MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 151 REST OF EUROPE: MICE MODEL MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 152 REST OF EUROPE: MICE MODEL MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.3.7 EUROPE: RECESSION IMPACT
  • 10.4 ASIA PACIFIC
    • FIGURE 26 ASIA PACIFIC: MICE MODEL MARKET SNAPSHOT
    • TABLE 153 ASIA PACIFIC: MICE MODEL MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 154 ASIA PACIFIC: MICE MODEL MARKET, BY MODEL TYPE AND SERVICE, 2021-2028 (USD MILLION)
    • TABLE 155 ASIA PACIFIC: MICE MODEL MARKET, BY MODEL TYPE, 2021-2028 (USD MILLION)
    • TABLE 156 ASIA PACIFIC: MICE MODEL MARKET, BY SERVICE, 2021-2028 (USD MILLION)
    • TABLE 157 ASIA PACIFIC: MICE MODEL MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 158 ASIA PACIFIC: MICE MODEL MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 159 ASIA PACIFIC: MICE MODEL MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.4.1 JAPAN
      • 10.4.1.1 Increasing focus on advancements in mice model technologies to drive market
    • TABLE 160 JAPAN: MICE MODEL MARKET, BY MODEL TYPE AND SERVICE, 2021-2028 (USD MILLION)
    • TABLE 161 JAPAN: MICE MODEL MARKET, BY MODEL TYPE, 2021-2028 (USD MILLION)
    • TABLE 162 JAPAN: MICE MODEL MARKET, BY SERVICE, 2021-2028 (USD MILLION)
    • TABLE 163 JAPAN: MICE MODEL MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 164 JAPAN: MICE MODEL MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 165 JAPAN: MICE MODEL MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.4.2 CHINA
      • 10.4.2.1 International alliances for R&D activities to drive adoption of mice models
    • TABLE 166 CHINA: MICE MODEL MARKET, BY MODEL TYPE AND SERVICE, 2021-2028 (USD MILLION)
    • TABLE 167 CHINA: MICE MODEL MARKET, BY MODEL TYPE, 2021-2028 (USD MILLION)
    • TABLE 168 CHINA: MICE MODEL MARKET, BY SERVICE, 2021-2028 (USD MILLION)
    • TABLE 169 CHINA: MICE MODEL MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 170 CHINA: MICE MODEL MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 171 CHINA: MICE MODEL MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.4.3 INDIA
      • 10.4.3.1 Rising initiatives in drug discovery development to fuel uptake of inbred mice
    • TABLE 172 INDIA: MICE MODEL MARKET, BY MODEL TYPE AND SERVICE, 2021-2028 (USD MILLION)
    • TABLE 173 INDIA: MICE MODEL MARKET, BY MODEL TYPE, 2021-2028 (USD MILLION)
    • TABLE 174 INDIA: MICE MODEL MARKET, BY SERVICE, 2021-2028 (USD MILLION)
    • TABLE 175 INDIA: MICE MODEL MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 176 INDIA: MICE MODEL MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 177 INDIA: MICE MODEL MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.4.4 SOUTH KOREA
      • 10.4.4.1 Rising R&D investments in drug development to fuel uptake for genetically engineered mice models
    • TABLE 178 SOUTH KOREA: MICE MODEL MARKET, BY MODEL TYPE AND SERVICE, 2021-2028 (USD MILLION)
    • TABLE 179 SOUTH KOREA: MICE MODEL MARKET, BY MODEL TYPE, 2021-2028 (USD MILLION)
    • TABLE 180 SOUTH KOREA: MICE MODEL MARKET, BY SERVICE, 2021-2028 (USD MILLION)
    • TABLE 181 SOUTH KOREA: MICE MODEL MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 182 SOUTH KOREA: MICE MODEL MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 183 SOUTH KOREA: MICE MODEL MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.4.5 AUSTRALIA
      • 10.4.5.1 High number of research institutes to drive market for mouse-based clinical trials
    • TABLE 184 AUSTRALIA: MICE MODEL MARKET, BY MODEL TYPE AND SERVICE, 2021-2028 (USD MILLION)
    • TABLE 185 AUSTRALIA: MICE MODEL MARKET, BY MODEL TYPE, 2021-2028 (USD MILLION)
    • TABLE 186 AUSTRALIA: MICE MODEL MARKET, BY SERVICE, 2021-2028 (USD MILLION)
    • TABLE 187 AUSTRALIA: MICE MODEL MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 188 AUSTRALIA: MICE MODEL MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 189 AUSTRALIA: MICE MODEL MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.4.6 REST OF ASIA PACIFIC
    • TABLE 190 REST OF ASIA PACIFIC: MICE MODEL MARKET, BY MODEL TYPE AND SERVICE, 2021-2028 (USD MILLION)
    • TABLE 191 REST OF ASIA PACIFIC: MICE MODEL MARKET, BY MODEL TYPE, 2021-2028 (USD MILLION)
    • TABLE 192 REST OF ASIA PACIFIC: MICE MODEL MARKET, BY SERVICE, 2021-2028 (USD MILLION)
    • TABLE 193 REST OF ASIA PACIFIC: MICE MODEL MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 194 REST OF ASIA PACIFIC: MICE MODEL MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 195 REST OF ASIA PACIFIC: MICE MODEL MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.4.7 ASIA PACIFIC: RECESSION IMPACT
  • 10.5 LATIN AMERICA
    • 10.5.1 GROWING PHARMACEUTICAL INDUSTRY AND DRUG DEVELOPMENT ACTIVITIES TO SUPPORT MARKET GROWTH
    • TABLE 196 LATIN AMERICA: MICE MODEL MARKET, BY MODEL TYPE AND SERVICE, 2021-2028 (USD MILLION)
    • TABLE 197 LATIN AMERICA: MICE MODEL MARKET, BY MODEL TYPE, 2021-2028 (USD MILLION)
    • TABLE 198 LATIN AMERICA: MICE MODEL MARKET, BY SERVICE, 2021-2028 (USD MILLION)
    • TABLE 199 LATIN AMERICA: MICE MODEL MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 200 LATIN AMERICA: MICE MODEL MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 201 LATIN AMERICA: MICE MODEL MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.5.2 LATIN AMERICA: RECESSION IMPACT
  • 10.6 MIDDLE EAST & AFRICA
    • 10.6.1 RISING EXPANSION OF PHARMACEUTICAL FACTORIES TO SUPPORT MARKET GROWTH
    • TABLE 202 MIDDLE EAST & AFRICA: MICE MODEL MARKET, BY MODEL TYPE AND SERVICE, 2021-2028 (USD MILLION)
    • TABLE 203 MIDDLE EAST & AFRICA: MICE MODEL MARKET, BY MODEL TYPE, 2021-2028 (USD MILLION)
    • TABLE 204 MIDDLE EAST & AFRICA: MICE MODEL MARKET, BY SERVICE, 2021-2028 (USD MILLION)
    • TABLE 205 MIDDLE EAST & AFRICA: MICE MODEL MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 206 MIDDLE EAST & AFRICA: MICE MODEL MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 207 MIDDLE EAST & AFRICA: MICE MODEL MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT

11 COMPETITIVE LANDSCAPE

  • 11.1 INTRODUCTION
  • 11.2 STRATEGIES ADOPTED BY KEY PLAYERS
    • FIGURE 27 MICE MODEL MARKET: STRATEGIES ADOPTED BY KEY PLAYERS
  • 11.3 REVENUE SHARE ANALYSIS (TOP 4 PLAYERS)
    • FIGURE 28 REVENUE ANALYSIS FOR TOP 4 COMPANIES (2020-2022)
    • FIGURE 29 MICE MODEL MARKET: MARKET SHARE ANALYSIS OF TOP 4 PLAYERS (2022)
  • 11.4 COMPANY EVALUATION QUADRANT FOR GLOBAL PLAYERS
    • 11.4.1 STARS
    • 11.4.2 EMERGING LEADERS
    • 11.4.3 PERVASIVE PLAYERS
    • 11.4.4 PARTICIPANTS
    • FIGURE 30 MICE MODEL MARKET: COMPANY EVALUATION MATRIX FOR GLOBAL PLAYERS (2022)
  • 11.5 COMPANY EVALUATION QUADRANT FOR STARTUPS/SMES
    • 11.5.1 PROGRESSIVE COMPANIES
    • 11.5.2 STARTING BLOCKS
    • 11.5.3 RESPONSIVE COMPANIES
    • 11.5.4 DYNAMIC COMPANIES
    • FIGURE 31 MICE MODEL MARKET: STARTUPS/SMES EVALUATION QUADRANT (2022)
    • 11.5.5 COMPETITIVE BENCHMARKING
      • 11.5.5.1 Mice Model Market: List of Startups/SMEs
    • TABLE 208 MICE MODEL MARKET: DETAILED LIST OF STARTUPS/SMES
      • 11.5.5.2 Mice Model Market: Competitive Benchmarking Of Key Players (Startups/SMEs)
    • TABLE 209 MICE MODEL MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS (STARTUPS/SMES)
  • 11.6 COMPETITIVE SCENARIO AND TRENDS
    • 11.6.1 PRODUCT LAUNCHES
    • TABLE 210 MICE MODEL MARKET: PRODUCT LAUNCHES
    • 11.6.2 DEALS
    • TABLE 211 MICE MODEL MARKET: DEALS
    • 11.6.3 OTHER DEVELOPMENTS
    • TABLE 212 MICE MODEL MARKET: OTHER DEVELOPMENTS

12 COMPANY PROFILES

  • 12.1 KEY PLAYERS
  • (Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)**
    • 12.1.1 CHARLES RIVER LABORATORIES
    • TABLE 213 CHARLES RIVER LABORATORIES: COMPANY OVERVIEW
    • FIGURE 32 CHARLES RIVER LABORATORIES: COMPANY SNAPSHOT (2022)
    • 12.1.2 THE JACKSON LABORATORY
    • TABLE 214 THE JACKSON LABORATORY: COMPANY OVERVIEW
    • FIGURE 33 THE JACKSON LABORATORY: COMPANY SNAPSHOT
    • 12.1.3 INOTIV
    • TABLE 215 INOTIV: COMPANY OVERVIEW
    • FIGURE 34 INOTIV: COMPANY SNAPSHOT
    • 12.1.4 GENOWAY
    • TABLE 216 GENOWAY: COMPANY OVERVIEW
    • FIGURE 35 GENOWAY: COMPANY SNAPSHOT (2022)
    • 12.1.5 TACONIC BIOSCIENCES, INC.
    • TABLE 217 TACONIC BIOSCIENCES, INC.: COMPANY OVERVIEW
    • 12.1.6 JANVIER LABS
    • TABLE 218 JANVIER LABS: COMPANY OVERVIEW
    • 12.1.7 HARBOUR BIOMED
    • TABLE 219 HARBOUR BIOMED: BUSINESS OVERVIEW
    • FIGURE 36 HARBOUR BIOMED: COMPANY SNAPSHOT (2021)
    • 12.1.8 TRANS GENIC INC.
    • TABLE 220 TRANS GENIC INC.: COMPANY OVERVIEW
    • FIGURE 37 TRANS GENIC INC.: COMPANY SNAPSHOT (2021)
    • 12.1.9 INGENIOUS TARGETING LABORATORY
    • TABLE 221 INGENIOUS TARGETING LABORATORY: COMPANY OVERVIEW
    • 12.1.10 POLYGENE
    • TABLE 222 POLYGENE AG: COMPANY OVERVIEW
    • 12.1.11 ARAGEN LIFE SCIENCES LTD.
    • TABLE 223 ARAGEN LIFE SCIENCES LTD.: COMPANY OVERVIEW
    • 12.1.12 CYAGEN BIOSCIENCES
    • TABLE 224 CYAGEN BIOSCIENCES: COMPANY OVERVIEW
    • 12.1.13 CROWN BIOSCIENCE
    • TABLE 225 CROWN BIOSCIENCE: BUSINESS OVERVIEW
    • 12.1.14 TRANSCURE BIOSERVICES
    • TABLE 226 TRANSCURE BIOSERVICES: COMPANY OVERVIEW
    • 12.1.15 OZGENE PTY LTD.
    • TABLE 227 OZGENE PTY LTD.: BUSINESS OVERVIEW
  • *Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
  • 12.2 OTHER PLAYERS
    • 12.2.1 THE ANDERSONS, INC.
    • 12.2.2 ALLENTOWN, LLC
    • 12.2.3 INNOVIVE
    • 12.2.4 LAB PRODUCTS, LLC.
    • 12.2.5 CRESCENDO BIOLOGICS
    • 12.2.6 IMMUNOGENES
    • 12.2.7 LEXICON PHARMACEUTICALS, INC.
    • 12.2.8 HORIZON DISCOVERY LTD.
    • 12.2.9 MARSHALL BIORESOURCES
    • 12.2.10 APPLIED STEMCELL

13 APPENDIX

  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3 CUSTOMIZATION OPTIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS